Optionele productanalyse
Met uw toestemming gebruiken we privacyvriendelijke, beperkte analyses om te begrijpen welke onderzoeksroutes werken. We gebruiken geen advertentietrackers of sessieopnamen. U kunt deze keuze wijzigen in Voorkeuren. Lees het Privacybeleid.
KLA Corporation's published Sell conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $242.5B | |
|---|---|---|
| Revenue (ttm) | 13.6B | |
| Net income (ttm) | 4.8B | |
| EPS (ttm) | $3.66 | |
| Shares out | 1.3B | |
| P/E (trailing) | 43.3x | |
| P/E (forward) | 31.9x | |
| Dividend | $0.92 (0.58%) | |
| Volume | 7,943,102 | |
| Beta | 1.45 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | 2026-06-30 | Trend |
| Revenue | $9.21B | $10.50B | $9.81B | $12.16B | $13.58B | +10.2% |
| Gross profit | $5.62B | $6.28B | $5.88B | $7.40B | $8.32B | +10.3% |
| Operating income | $3.65B | $4.09B | $3.50B | $4.95B | $5.66B | +11.6% |
| Net income | $3.32B | $3.39B | $2.76B | $4.06B | $4.83B | +9.8% |
| EPS (diluted) | $2.19 | $2.42 | $2.03 | $3.04 | $3.66 | +13.7% |
| EBITDA | $4.01B | $4.50B | $3.90B | $5.34B | $5.76B | +9.5% |
| R&D | $1.11B | $1.30B | $1.28B | $1.36B | $1.53B | +8.5% |
| SG&A | $860.0M | $986.3M | $969.5M | $1.03B | $1.13B | +7.1% |
Recent company headlines from major financial publishers.
Better component availability supports growth while FY2026 profitability holds. Weaker annual revenue expectations or sustained margin erosion by FY2028 would disconfirm it.
Core growth and profitability must persist without a large internal capital build. Renewed shipment limits or weaker margins by FY2028 would disconfirm it.
| Ke ↓ / g → | 2.0% | 2.5% | 3.0% | 3.5% | 4.0% |
|---|---|---|---|---|---|
| 8.4% | $126 | $131 | $137 | $143 | $152 |
| 9.4% | $113 | $117 | $120 | $125 | $130 |
| 10.4% | $103 | $106 | $109 | $111 | $115 |
| 11.4% | $95.1 | $96.9 | $98.9 | $101 | $104 |
| 12.4% | $88.4 | $89.7 | $91.2 | $92.9 | $94.7 |
Upcoming earnings date and setup when available.
De rating die de gepubliceerde researcheditie van elke maand droeg. Een rating vergelijkt de koers op de analysedatum met de fair value; het is geen overzicht van of de inschatting juist bleek.
| Jaar | jan | feb | mrt | apr | mei | jun | jul | aug | sep | okt | nov | dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |